These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11940319)

  • 1. [The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus].
    Wang H; Deng H; Liu W
    Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):179-82. PubMed ID: 11940319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ; Braschi S; Willis G; Astley SB
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
    Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
    Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized-LDL and paraoxonase-1 as biomarkers of coronary artery disease in patients with sleep-disordered breathing.
    Hackenhaar FS; Martinez D; Medeiros TM; Klein C; Alabarse PV; Wainstein MV; Gonçalves SC; Benfato MS
    Curr Med Chem; 2012; 19(25):4359-66. PubMed ID: 22934769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
    Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
    Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria.
    Paniagua JA; López-Miranda J; Pérez-Martínez P; Marín C; Vida JM; Fuentes F; Fernández de la Puebla RA; Pérez-Jiménez F
    Diabet Med; 2005 Dec; 22(12):1647-56. PubMed ID: 16401307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes.
    Morteza A; Nakhjavani M; Ghadiri-Anari A; Esteghamati A; Khalilzadeh O
    Eur Cytokine Netw; 2011 Jun; 22(2):107-12. PubMed ID: 21636350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
    Kimak E; Hałabiś M; Baranowicz-Gąszczyk I; Solski J; Książek A
    J Zhejiang Univ Sci B; 2011 May; 12(5):365-71. PubMed ID: 21528490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus.
    Nakhjavani M; Asgharani F; Khalilzadeh O; Esteghamati A; Ghaneei A; Morteza A; Anvari M
    Am J Med Sci; 2011 Feb; 341(2):92-5. PubMed ID: 20890173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.
    Tsuzura S; Ikeda Y; Suehiro T; Ota K; Osaki F; Arii K; Kumon Y; Hashimoto K
    Metabolism; 2004 Mar; 53(3):297-302. PubMed ID: 15015140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.
    Sonoki K; Iwase M; Sasaki N; Ohdo S; Higuchi S; Matsuyama N; Iida M
    Diabetes Res Clin Pract; 2009 Nov; 86(2):117-23. PubMed ID: 19748147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients: a cross-sectional study.
    Nakhjavani M; Esteghamati A; Asgarani F; Khalilzadeh O; Nikzamir A; Safari R
    Transl Res; 2009 Feb; 153(2):86-90. PubMed ID: 19138653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus].
    Shi X; Zhang Y; Niu H; Wang R; Shen J; Zhou S; Yang H; Wang S; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):143-50. PubMed ID: 26932211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated beta2-glycoprotein I-low-density lipoprotein levels are associated with the presence of diabetic microvascular complications.
    Yu R; Yuan Y; Niu D; Song J; Liu T; Wu J; Wang J
    J Diabetes Complications; 2015; 29(1):59-63. PubMed ID: 25449980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.